11/02/2004
Galen on course to double profits
NI-based pharmaceuticals company Galen has reported pre-tax profits of £26 million for the first quarter of the year, and is on course to double annual profits.
The massive rise in profits for the Craigavon pharmaceuticals firm that procures a large slice of its profits from the US market prompted Galen's Chief Executive Roger Boissonneault to comment: "During the first quarter of our 2004 financial year, the Company has generated revenues in excess of $140 million, illustrating the excellent product portfolio that we have to drive future growth.
"With our two sales forces now fully in place, we look forward to the rest of 2004 with confidence."
During the company's last financial quarter, Galen announced the completion of the deployment of a 186-strong sales force in the Warner Chilcott Specialty pharmaceutical drug division.
The firm is one of Northern Ireland's most lucrative enterprises following the acquisition of US firm Warner Chilcott for just under £220 million in 2000.
Among the firm's main product lines are contraceptive pills and drugs used for hormone replacement therapy.
(SP)
The massive rise in profits for the Craigavon pharmaceuticals firm that procures a large slice of its profits from the US market prompted Galen's Chief Executive Roger Boissonneault to comment: "During the first quarter of our 2004 financial year, the Company has generated revenues in excess of $140 million, illustrating the excellent product portfolio that we have to drive future growth.
"With our two sales forces now fully in place, we look forward to the rest of 2004 with confidence."
During the company's last financial quarter, Galen announced the completion of the deployment of a 186-strong sales force in the Warner Chilcott Specialty pharmaceutical drug division.
The firm is one of Northern Ireland's most lucrative enterprises following the acquisition of US firm Warner Chilcott for just under £220 million in 2000.
Among the firm's main product lines are contraceptive pills and drugs used for hormone replacement therapy.
(SP)
Related Northern Ireland News Stories
Click here for the latest headlines.
14 November 2024
Health Minister Seeks Urgent Talks On Pay
The Health Minister has confirmed that he has requested an early meeting with health service trade unions to discuss next steps on pay offers for 2024/25. Due to Northern Ireland's budgetary constraints, the Minister is unable to deliver the desired pay settlements for this year.
Health Minister Seeks Urgent Talks On Pay
The Health Minister has confirmed that he has requested an early meeting with health service trade unions to discuss next steps on pay offers for 2024/25. Due to Northern Ireland's budgetary constraints, the Minister is unable to deliver the desired pay settlements for this year.
19 November 2024
Seating Matters To Create 62 New Jobs In £3.7m Investment
Economy Minister Conor Murphy has announced a significant investment by Seating Matters, a leading global manufacturer of therapeutic seating solutions. The company will invest £3.7 million in its facilities in Limavady and Derry, creating 62 new jobs over the next two years.
Seating Matters To Create 62 New Jobs In £3.7m Investment
Economy Minister Conor Murphy has announced a significant investment by Seating Matters, a leading global manufacturer of therapeutic seating solutions. The company will invest £3.7 million in its facilities in Limavady and Derry, creating 62 new jobs over the next two years.
14 November 2002
US growth aids Galen profits gain
Improved growth in the United States has helped Craigavon-based, Galen Holdings post its strongest set of results since flotation in 1997. The pharmaceutical company revealed that profits rose to £101m from £41m over the past year while revenues for the past 12 months rose to £102m from last year's £187m.
US growth aids Galen profits gain
Improved growth in the United States has helped Craigavon-based, Galen Holdings post its strongest set of results since flotation in 1997. The pharmaceutical company revealed that profits rose to £101m from £41m over the past year while revenues for the past 12 months rose to £102m from last year's £187m.
22 August 2011
Recession Hits Gilbert Ash's Profits
The construction firm behind the acclaimed rebuilding of south Belfast's iconic Lyric Theatre, Gilbert Ash, has been filing its accounts. And while the Belfast-based construction firm Gilbert has reported pre-tax profits of nearly £700,000 for 2010 on a turnover of £94m, when compared to the previous year, both turnover and profits were down.
Recession Hits Gilbert Ash's Profits
The construction firm behind the acclaimed rebuilding of south Belfast's iconic Lyric Theatre, Gilbert Ash, has been filing its accounts. And while the Belfast-based construction firm Gilbert has reported pre-tax profits of nearly £700,000 for 2010 on a turnover of £94m, when compared to the previous year, both turnover and profits were down.
23 August 2010
Kingspan Reigns Supreme
Just six months after the building materials supplier Kingspan recorded falling profits and sales, a major turn-round in fortunes has seen the firm make its first operating profit in three years. The Cavan-based company, which has a factory in Portadown, said profits from January to June rose to €33m - up 9% on last year.
Kingspan Reigns Supreme
Just six months after the building materials supplier Kingspan recorded falling profits and sales, a major turn-round in fortunes has seen the firm make its first operating profit in three years. The Cavan-based company, which has a factory in Portadown, said profits from January to June rose to €33m - up 9% on last year.